Literature DB >> 874362

Adaptation of TSH filter paper method for regionalized screening for congenital hypothyroidism.

T P Foley, A H Klein, A V Agustin.   

Abstract

A sensitive, specific, rapid radioimmunoassay is described for the determination of thyrotropin (TSH) in eluates from two 3 mm discs punched from dried blood filter-paper specimens. This method is sufficiently sensitive to easily discriminate between normal infants and infants with primary hypothyroidism. The use of two 3 mm discs enables screening laboratories to easily incorporate this methodology into the currently available, fully automated systems to screen for several metabolic disorders. Since mental retardation occurs in untreated infants with primary hypothyroidism, our TSH method as the primary screening test alone, or in association with a thyroxine (T4) screening test, should detect all infants with primary hypothyroidism with a very acceptable low false-positive recall rate.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 874362

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  4 in total

1.  Results of a regional cord blood screening programme for detecting neonatal hypothyroidism.

Authors:  P G Walfish; J Ginsberg; R A Rosenberg; N J Howard
Journal:  Arch Dis Child       Date:  1979-03       Impact factor: 3.791

2.  Pilot study for congenital hypothyroidism, preliminary report.

Authors:  M Carta Sorcini; L Fiore; S Tomarchio; S Carta; C Romagnoli; V Currò; G Segni
Journal:  J Endocrinol Invest       Date:  1980 Apr-Jun       Impact factor: 4.256

3.  Evaluation of congenital hypothyroidism in fars province, iran.

Authors:  Zohreh Karamizadeh; Hedyeh Saneifard; Golmhossein Amirhakimi; Hamdollah Karamifar; Mehrsadat Alavi
Journal:  Iran J Pediatr       Date:  2012-03       Impact factor: 0.364

Review 4.  Congenital hypothyroidism screening program in iran; a systematic review and metaanalysis.

Authors:  Yousef Veisani; Kourosh Sayehmiri; Shahab Rezaeian; Ali Delpisheh
Journal:  Iran J Pediatr       Date:  2014-10-06       Impact factor: 0.364

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.